Abstract
Background
The Veterans Health Administration provides care to more than 100,000 Veterans with cirrhosis.
Aims
This implementation evaluation aimed to understand organizational resources and barriers associated with cirrhosis care.
Methods
Clinicians across 145 Department of Veterans Affairs (VA) medical centers (VAMCs) were surveyed in 2022 about implementing guideline-concordant cirrhosis care. VA Corporate Data Warehouse data were used to assess VAMC performance on two national cirrhosis quality measures: HCC surveillance and esophageal variceal surveillance or treatment (EVST). Organizational factors associated with higher performance were identified using linear regression models.
Results
Responding VAMCs (n = 124, 86%) ranged in resource availability, perceived barriers, and care processes. In multivariable models, factors independently associated with HCC surveillance included on-site interventional radiology and identifying patients overdue for surveillance using a national cirrhosis population management tool (“dashboard”). EVST was significantly associated with dashboard use and on-site gastroenterology services. For larger VAMCs, the average HCC surveillance rate was similar between VAMCs using vs. not using the dashboard (47% vs. 41%), while for smaller and less resourced VAMCs, dashboard use resulted in a 13% rate difference (46% vs. 33%). Likewise, higher EVST rates were more strongly associated with dashboard use in smaller (55% vs. 50%) compared to larger (57% vs. 55%) VAMCs.
Conclusions
Resources, barriers, and care processes varied across diverse VAMCs. Smaller VAMCs without specialty care achieved HCC and EVST surveillance rates nearly as high as more complex and resourced VAMCs if they used a population management tool to identify the patients due for cirrhosis care.
Similar content being viewed by others
Abbreviations
- CDW:
-
Corporate Data Warehouse
- CFIR:
-
Consolidated Framework for Implementation Research
- EVST:
-
Esophageal variceal surveillance or treatment
- FAB:
-
Field Advisory Board
- NGHP:
-
National Gastroenterology and Hepatology Program
- VA:
-
Department of Veterans Affairs
- VAMC:
-
VA medical centers
- VHA:
-
Veterans Health Administration
References
Chen CM, Yoon Y. Surveillance Report #118: Liver Cirrhosis Mortality in the United States: National, State, and Regional Trends, 2000–2019. 2022; https://www.niaaa.nih.gov/sites/default/files/surveillance-report118.pdf. Accessed August 16, 2023.
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788.
Morales BP, Planas R, Bartoli R et al. HEPACONTROL. A program that reduces early readmissions, mortality at 60 days, and healthcare costs in decompensated cirrhosis. Dig Liver Dis. 2018;50(1):76–83.
Gaspar R, Rodrigues S, Silva M et al. Predictive models of mortality and hospital readmission of patients with decompensated liver cirrhosis. Dig Liver Dis. 2019;51(10):1423–1429.
Serper M, Kaplan DE, Shults J et al. Quality measures, all-cause mortality, and health care use in a national cohort of veterans with cirrhosis. Hepatology. 2019;70(6):2062–2074.
Singal AG, Zhang E, Narasimman M et al. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis. J Hepatol. 2022;77(1):128–139.
Yang JD, Mannalithara A, Piscitello AJ et al. Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis. Hepatology. 2018;68(1):78–88.
Wu CY, Hsu YC, Ho HJ, Chen YJ, Lee TY, Lin JT. Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study. Gut. 2016;65(4):693–701.
Heimbach JK. Overview of the Updated AASLD Guidelines for the Management of HCC. Gastroenterol Hepatol (N Y). 2017;13(12):751–753.
Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65(1):310–335.
Jakab SS, Garcia-Tsao G. Screening and surveillance of varices in patients with cirrhosis. Clin Gastroenterol Hepatol. 2019;17(1):26–29.
Kanwal F, Tapper EB, Ho C et al. Development of quality measures in cirrhosis by the practice metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2019;69(4):1787–1797.
Veterans Health Administration. About VHA. https://www.va.gov/health/aboutVHA.asp. Accessed August 16, 2023.
Beste LA, Leipertz SL, Green PK, Dominitz JA, Ross D, Ioannou GN. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001–2013. Gastroenterology. 2015;149(6):1471–1482 (quiz e17-8).
Moodley J, Lopez R, Carey W. Compliance with practice guidelines and risk of a first esophageal variceal hemorrhage in patients with cirrhosis. Clin Gastroenterol Hepatol. 2010;8(8):703–708.
Goldberg DS, Valderrama A, Kamalakar R, Sansgiry SS, Babajanyan S, Lewis JD. Hepatocellular carcinoma surveillance rates in commercially insured patients with noncirrhotic chronic hepatitis B. J Viral Hepatitis. 2015;22(9):727–736.
Kanwal F, Kramer J, Asch SM et al. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol. 2010;8(8):709–717.
Kanwal F, Kramer JR, Buchanan P et al. The quality of care provided to patients with cirrhosis and ascites in the Department of Veterans Affairs. Gastroenterology. 2012;143(1):70–77.
Korom-Djakovic D, Canamucio A, Lempa M, Yano EM, Long JA. Organization complexity and primary care providers’ perceptions of quality improvement culture within the Veterans Health Administration. Am J Med Qual. 2016;31(2):139–146.
Department of Veterans Affairs Office of Research & Development. VHA Operations Activities That May Constitute Research. 2019; https://www.research.va.gov/resources/policies/ProgramGuide-1200-21-VHA-Operations-Activities.pdf. Accessed August 16, 2023.
CFIR Research Team. Consolidated Framework for Implementation Research. https://cfirguide.org/. Accessed August 16, 2023.
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.
Damschroder LJ, Lowery JC. Evaluation of a large-scale weight management program using the consolidated framework for implementation research (CFIR). Implement Sci. 2013;8:51.
Rogal SS, Yakovchenko V, Waltz TJ et al. The association between implementation strategy use and the uptake of hepatitis C treatment in a national sample. Implement Sci. 2017;12(1):60.
Lapointe-Shaw L, Georgie F, Carlone D et al. Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study. PLoS ONE. 2018;13(8):e0201120.
Hayward KL, Johnson AL, McKillen BJ et al. ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies. BMJ Open Gastroenterol. 2020;7(1):e000485.
Burkholder DA, Moran IJ, DiBattista JV, Lok AS, Parikh ND, Chen VL. Accuracy of international classification of diseases-10 codes for cirrhosis and portal hypertensive complications. Dig Dis Sci. 2022;67(8):3623–3631. https://doi.org/10.1007/s10620-021-07282-x
National Academies of Sciences, Engineering, Medicine. Appendix C: Nature of Veterans Health Administration Facilities Management (Engineering) Tasks and Staffing. In. Facilities Staffing Requirements for the Veterans Health Administration–Resource Planning and Methodology for the Future. Washington, DC: The National Academies Press; 2020.
R Core Team (2022). R: A language and environment for statistical computing. https://www.R-project.org. Accessed August 16, 2023.
Rogal SS, Chinman M, Gellad WF et al. Tracking implementation strategies in the randomized rollout of a Veterans Affairs national opioid risk management initiative. Implement Sci. 2020;15(1):48.
Rogal SS, Yakovchenko V, Gonzalez R et al. The hepatic innovation team collaborative: a successful population-based approach to hepatocellular carcinoma surveillance. Cancers (Basel). 2021;13(9):2251.
Rogal SS, Yakovchenko V, Morgan T et al. Getting to implementation: a protocol for a Hybrid III stepped wedge cluster randomized evaluation of using data-driven implementation strategies to improve cirrhosis care for Veterans. Implement Sci. 2020;15(1):92.
Funding
Funding for this quality improvement project was provided by the Department of Veterans Affairs National Gastroenterology and Hepatology Program Office. Funding for Dr. Rogal’s time was provided in part by grant K23DA048182 from the National Institute on Drug Abuse. The views expressed here are those of the authors and do not represent those of the Department of Veterans Affairs, the National Institutes of Health, or the United States Government.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Baffy consults for iota Biosciences. The remaining authors have no conflict to report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
McCurdy, H., Nobbe, A., Scott, D. et al. Organizational and Implementation Factors Associated with Cirrhosis Care in the Veterans Health Administration. Dig Dis Sci (2024). https://doi.org/10.1007/s10620-024-08409-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10620-024-08409-6